-
1
-
-
20544455330
-
Bevacizumab (avastin), a humanized anti-vegf monoclonal antibody for cancer therapy
-
Ferrara N, Hillan KJ, Novotny W. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 2005;333:328-34
-
(2005)
Biochem Biophys Res Commun
, vol.333
, pp. 328-34
-
-
Ferrara, N.1
Hillan, K.J.2
Novotny, W.3
-
3
-
-
43249114808
-
A new weapon for attacking tumor blood vessels
-
Semenza GL. A new weapon for attacking tumor blood vessels. N Engl J Med 2008;358:2066-7
-
(2008)
N Engl J Med
, vol.358
, pp. 2066-7
-
-
Semenza, G.L.1
-
4
-
-
23044505200
-
Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration
-
Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-4
-
(2005)
Ophthalmic Surg Lasers Imaging
, vol.36
, pp. 331-4
-
-
Rosenfeld, P.J.1
Moshfeghi, A.A.2
Puliafito, C.A.3
-
5
-
-
65349108729
-
Bevacizumab (avastin) for the treatment of ocular disease
-
Gunther JB, Altaweel MM. Bevacizumab (Avastin) for the treatment of ocular disease. Surv Ophthalmol 2009;54:372-400
-
(2009)
Surv Ophthalmol
, vol.54
, pp. 372-400
-
-
Gunther, J.B.1
Altaweel, M.M.2
-
6
-
-
34548141828
-
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
-
DOI 10.1093/jnci/djm086
-
Scappaticci FA, Skillings JR, Holden SN, et al. Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst 2007;99:1232-9 (Pubitemid 47299901)
-
(2007)
Journal of the National Cancer Institute
, vol.99
, Issue.16
, pp. 1232-1239
-
-
Scappaticci, F.A.1
Skillings, J.R.2
Holden, S.N.3
Gerber, H.-P.4
Miller, K.5
Kabbinavar, F.6
Bergsland, E.7
Ngai, J.8
Holmgren, E.9
Wang, J.10
Hurwitz, H.11
-
7
-
-
38149028284
-
Reversible posterior leukoencephalopathy syndrome in cancer
-
Vaughn C, Zhang L, Schiff D. Reversible posterior leukoencephalopathy syndrome in cancer. Curr Oncol Rep 2008;10:86-91
-
(2008)
Curr Oncol Rep
, vol.10
, pp. 86-91
-
-
Vaughn, C.1
Zhang, L.2
Schiff, D.3
-
8
-
-
34247231012
-
The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: A single institutional survey
-
PII 0124389420060600000023
-
Velcheti V, Viswanathan A, Govindan R. The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: a single institutional survey. J Thorac Oncol 2006;1:501 (Pubitemid 47181431)
-
(2006)
Journal of Thoracic Oncology
, vol.1
, Issue.5
, pp. 501
-
-
Velcheti, V.1
Viswanathan, A.2
Govindan, R.3
-
9
-
-
40849130173
-
VEGF inhibition and renal thrombotic microangiopathy
-
DOI 10.1056/NEJMoa0707330
-
Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008;358:1129-36 This paper describes features of thrombotic microangiopathy after bevacizumab therapy in patients and provides direct experimental evidence of a mechanism of glomerular injury by VEGF inhibitors in a mouse model. (Pubitemid 351398487)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.11
, pp. 1129-1136
-
-
Eremina, V.1
Jefferson, J.A.2
Kowalewska, J.3
Hochster, H.4
Haas, M.5
Weisstuch, J.6
Richardson, C.7
Kopp, J.B.8
Kabir, M.G.9
Backx, P.H.10
Gerber, H.-P.11
Ferrara, N.12
Barisoni, L.13
Alpers, C.E.14
Quaggin, S.E.15
-
10
-
-
34347213068
-
Penetration of bevacizumab through the retina after intravitreal injection in the monkey
-
DOI 10.1167/iovs.06-1171
-
Heiduschka P, Fietz H, Hofmeister S, et al. Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Invest Ophthalmol Vis Sci 2007;48:2814-23 (Pubitemid 351261238)
-
(2007)
Investigative Ophthalmology and Visual Science
, vol.48
, Issue.6
, pp. 2814-2823
-
-
Heiduschka, P.1
Fietz, H.2
Hofmeister, S.3
Schultheiss, S.4
Mack, A.F.5
Peters, S.6
Ziemssen, F.7
Niggemann, B.8
Julien, S.9
Bartz-Schmidt, K.U.10
Schraermeyer, U.11
-
11
-
-
34248598513
-
Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab
-
This study shows activation of thrombocytes after intravitreal injection of bevacizumab into monkey eyes
-
Peters S, Heiduschka P, Julien S, et al. Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol 2007;143:995-1002 This study shows activation of thrombocytes after intravitreal injection of bevacizumab into monkey eyes.
-
(2007)
Am J Ophthalmol
, vol.143
, pp. 995-1002
-
-
Peters, S.1
Heiduschka, P.2
Julien, S.3
-
12
-
-
57749207937
-
Bevacizumab immune complexes activate platelets and induce thrombosis in fcgr2a transgenic mice
-
This is a key paper in the field. It provides a mechanism for thrombotic events observed in bevacizumab therapy
-
Meyer T, Robles-Carrillo L, Robson T, et al. Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice. J Thromb Haemost 2009;7:171-81 .This is a key paper in the field. It provides a mechanism for thrombotic events observed in bevacizumab therapy.
-
(2009)
J Thromb Haemost
, vol.7
, pp. 171-81
-
-
Meyer, T.1
Robles-Carrillo, L.2
Robson, T.3
-
13
-
-
79956218863
-
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
-
Martin DF, Maguire MG, Ying GS, et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011;364:1897-908
-
(2011)
N Engl J Med
, vol.364
, pp. 908
-
-
Martin, D.F.1
Maguire, M.G.2
Ying, G.S.3
-
14
-
-
79951560449
-
Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab
-
In this retrospective study, bevacizumab raised the risk of arterial thromboembolic events when compared to ranibizumab
-
Carneiro AM, Barthelmes D, Falcao MS, et al. Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab. Ophthalmologica 2011;225:211-21 . In this retrospective study, bevacizumab raised the risk of arterial thromboembolic events when compared to ranibizumab.
-
(2011)
Ophthalmologica
, vol.225
, pp. 211-21
-
-
Carneiro, A.M.1
Barthelmes, D.2
Falcao, M.S.3
-
15
-
-
80051865307
-
Emerging evidence concerning systemic safety of anti-vegf agents-should ophthalmologists be concerned?
-
Lim LS, Cheung CM, Mitchell P, et al. Emerging evidence concerning systemic safety of anti-VEGF agents-should ophthalmologists be concerned? Am J Ophthalmol 2011;152:329-31
-
(2011)
Am J Ophthalmol
, vol.152
, pp. 329-31
-
-
Lim, L.S.1
Cheung, C.M.2
Mitchell, P.3
-
16
-
-
79958228219
-
Characterization and allelic polymorphisms of rhesus macaque (macaca mulatta) igg fc receptor genes
-
Nguyen DC, Scinicariello F, Attanasio R. Characterization and allelic polymorphisms of rhesus macaque (Macaca mulatta) IgG Fc receptor genes. Immunogenetics 2011;63:351-62
-
(2011)
Immunogenetics
, vol.63
, pp. 351-62
-
-
Nguyen, D.C.1
Scinicariello, F.2
Attanasio, R.3
-
17
-
-
84866558151
-
Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye
-
This study shows reduction of choriocapillaris after intravitreal injection of bevacizumab into monkey eyes.
-
Schraermeyer U, Julien S. Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye. Graefes Arch Clin Exp Ophthalmol 2012;250:1303-1 .. This study shows reduction of choriocapillaris after intravitreal injection of bevacizumab into monkey eyes.
-
(2012)
Graefes Arch Clin Exp Ophthalmol
, vol.250
, pp. 1303-1
-
-
Schraermeyer, U.1
Julien, S.2
-
18
-
-
34547383713
-
Preparation of iodine-131 labelled human growth hormone of high specific activity
-
Hunter WM, Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962;194:495-6
-
(1962)
Nature
, vol.194
, pp. 495-6
-
-
Hunter, W.M.1
Greenwood, F.C.2
-
19
-
-
0013786550
-
The identification of platelets and platelet antigens in histological sections
-
Carstairs KC. The identification of platelets and platelet antigens in histological sections. J Pathol Bacteriol 1965;90:225-31
-
(1965)
J Pathol Bacteriol
, vol.90
, pp. 225-31
-
-
Carstairs, K.C.1
-
20
-
-
0032807809
-
Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris: Evidence for a trophic paracrine relation
-
Blaauwgeers HG, Holtkamp GM, Rutten H, et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol 1999;155:421-8 (Pubitemid 29370392)
-
(1999)
American Journal of Pathology
, vol.155
, Issue.2
, pp. 421-428
-
-
Blaauwgeers, H.G.T.1
Holtkamp, G.M.2
Rutten, H.3
Witmer, A.N.4
Koolwijk, P.5
Partanen, T.A.6
Alitalo, K.7
Kroon, M.E.8
Kijlstra, A.9
Van Hinsbergh, V.W.M.10
Schlingemann, R.O.11
-
21
-
-
77649253359
-
Fcrn receptor-mediated pharmacokinetics of therapeutic igg in the eye
-
Kim H, Robinson SB, Csaky KG. FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye. Mol Vis 2009;15:2803-12
-
(2009)
Mol Vis
, vol.15
, pp. 2803-12
-
-
Kim, H.1
Robinson, S.B.2
Csaky, K.G.3
-
22
-
-
0027844985
-
A soluble form of the human Fc receptor FcγRIIA: Cloning, transcript analysis and detection
-
Rappaport EF, Cassel DL, Walterhouse DO, et al. A soluble form of the human Fc receptor Fc gamma RIIA: cloning, transcript analysis and detection. Exp Hematol 1993;21:689-96 (Pubitemid 24212373)
-
(1993)
Experimental Hematology
, vol.21
, Issue.5
, pp. 689-696
-
-
Rappaport, E.F.1
Cassel, D.L.2
Walterhouse, D.O.3
McKenzie, S.E.4
Surrey, S.5
Keller, M.A.6
Schreiber, A.D.7
Schwartz, E.8
-
23
-
-
0027515012
-
Detection and quantification of secreted soluble fc gamma riia in human sera by an enzyme-linked immunosorbent assay
-
Astier A, de la Salle H, Moncuit J, et al. Detection and quantification of secreted soluble Fc gamma RIIA in human sera by an enzyme-linked immunosorbent assay. J Immunol Methods 1993;166:1-10
-
(1993)
J Immunol Methods
, vol.166
, pp. 1-10
-
-
Astier, A.1
De La Salle, H.2
Moncuit, J.3
-
24
-
-
0037505472
-
Soluble FcγRIIa inhibits rheumatoid factor binding to immune complexes
-
DOI 10.1046/j.1365-2567.2003.01652.x
-
Wines BD, Gavin A, Powell MS, et al. Soluble FcgammaRIIa inhibits rheumatoid factor binding to immune complexes. Immunology 2003;109:246-54 (Pubitemid 36683616)
-
(2003)
Immunology
, vol.109
, Issue.2
, pp. 246-254
-
-
Wines, B.D.1
Gavin, A.2
Powell, M.S.3
Steinitz, M.4
Buchanan, R.R.C.5
Hogarth, P.M.6
-
25
-
-
2442621619
-
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
-
Ferrara N, Hillan KJ, Gerber HP, et al. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 2004;3:391-400 (Pubitemid 38618122)
-
(2004)
Nature Reviews Drug Discovery
, vol.3
, Issue.5
, pp. 391-400
-
-
Ferrara, N.1
Hillan, K.J.2
Gerber, H.-P.3
Novotny, W.4
-
26
-
-
79958045498
-
Dynamics of a heparin-binding domain of vegf(165) complexed with its inhibitor triamterene
-
Jeong KW, Lee JY, Lee SA, et al. Dynamics of a heparin-binding domain of VEGF(165) complexed with its inhibitor triamterene. Biochemistry 2011;50:4843-54
-
(2011)
Biochemistry
, vol.50
, pp. 4843-54
-
-
Jeong, K.W.1
Lee, J.Y.2
Lee, S.A.3
-
27
-
-
84863075395
-
Binding affinities of vascular endothelial growth factor (vegf) for heparin-derived oligosaccharides
-
Zhao W, McCallum SA, Xiao Z, et al. Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides. Biosci Rep 2012;32:71-81
-
(2012)
Biosci Rep
, vol.32
, pp. 71-81
-
-
Zhao, W.1
McCallum, S.A.2
Xiao, Z.3
-
28
-
-
0025101122
-
A view of the human idiotypic repertoire. Electron microscopic and immunologic analyses of spontaneous idiotype-Anti-idiotype dimers in pooled human igg
-
Roux KH, Tankersley DL. A view of the human idiotypic repertoire. Electron microscopic and immunologic analyses of spontaneous idiotype-Anti-idiotype dimers in pooled human IgG. J Immunol 1990;144:1387-94
-
(1990)
J Immunol
, vol.144
, pp. 1387-94
-
-
Roux, K.H.1
Tankersley, D.L.2
-
29
-
-
77953944193
-
Interactions with heparin-like molecules during erythrocyte invasion by plasmodium falciparum merozoites
-
Boyle MJ, Richards JS, Gilson PR, et al. Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites. Blood 2010;115:4559-68
-
(2010)
Blood
, vol.115
, pp. 4559-68
-
-
Boyle, M.J.1
Richards, J.S.2
Gilson, P.R.3
-
30
-
-
0036025336
-
Fcγ receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro
-
DOI 10.1046/j.1365-2249.2002.01972.x
-
Tebo AE, Kremsner PG, Luty AJ. Fcgamma receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro. Clin Exp Immunol 2002;130:300-6 (Pubitemid 35286218)
-
(2002)
Clinical and Experimental Immunology
, vol.130
, Issue.2
, pp. 300-306
-
-
Tebo, A.E.1
Kremsner, P.G.2
Luty, A.J.F.3
-
31
-
-
0037443518
-
Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1α domain of PfEMP1
-
DOI 10.1182/blood-2002-07-2016
-
Vogt AM, Barragan A, Chen Q, et al. Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1. Blood 2003;101:2405-11 (Pubitemid 36302089)
-
(2003)
Blood
, vol.101
, Issue.6
, pp. 2405-2411
-
-
Vogt, A.M.1
Barragan, A.2
Chen, Q.3
Kironde, F.4
Spillmann, D.5
Wahlgren, M.6
-
32
-
-
4344631854
-
Heparan sulphate identified on human erythrocytes: A Plasmodium falciparum receptor
-
DOI 10.1042/BJ20040762
-
Vogt AM, Winter G, Wahlgren M, et al. Heparan sulphate identified on human erythrocytes: a Plasmodium falciparum receptor. Biochem J 2004;381:593-7 (Pubitemid 39120467)
-
(2004)
Biochemical Journal
, vol.381
, Issue.3
, pp. 593-597
-
-
Vogt, A.M.1
Winter, G.2
Wahlgren, M.3
Spillmann, D.4
-
33
-
-
0028171143
-
Role of neutrophil FcγRIIa (CD32) and FcγRIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes
-
Bredius RG, Fijen CA, De Haas M, et al. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- And IgG3-opsonized bacteria and erythrocytes. Immunology 1994;83:624-30 (Pubitemid 24374097)
-
(1994)
Immunology
, vol.83
, Issue.4
, pp. 624-630
-
-
Bredius, R.G.M.1
Fijen, C.A.P.2
De Haas, M.3
Kuijper, E.J.4
Weening, R.S.5
Van De Winkel, J.G.J.6
Out, T.A.7
-
35
-
-
77649227816
-
Retinal artery occlusion following intravitreal anti-vegf therapy
-
von Hanno T, Kinge B, Fossen K. Retinal artery occlusion following intravitreal anti-VEGF therapy. Acta Ophthalmol 2010;88:263-6
-
(2010)
Acta Ophthalmol
, vol.88
, pp. 263-6
-
-
Von Hanno, T.1
Kinge, B.2
Fossen, K.3
-
36
-
-
84864385517
-
Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys
-
Julien S, Schraermeyer U. Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys. Neurobiol Aging 2012;33:2390-7
-
(2012)
Neurobiol Aging
, vol.33
, pp. 2390-7
-
-
Julien, S.1
Schraermeyer, U.2
-
37
-
-
84856369109
-
The effect of intravitreal injection of bevacizumab on retinal circulation in patients with neovascular macular degeneration
-
This prospective study assesses the long-term effect of intravitreal bevacizumab on vascular tone and on retinal blood flow including the neuroretinal rim in AMD patients
-
Fontaine O, Olivier S, Descovich D, et al. The effect of intravitreal injection of bevacizumab on retinal circulation in patients with neovascular macular degeneration. Invest Ophthalmol Vis Sci 2011;52:7400-4 .. This prospective study assesses the long-term effect of intravitreal bevacizumab on vascular tone and on retinal blood flow including the neuroretinal rim in AMD patients.
-
(2011)
Invest Ophthalmol Vis Sci
, vol.52
, pp. 7400-4
-
-
Fontaine, O.1
Olivier, S.2
Descovich, D.3
-
38
-
-
84863316257
-
The effect of intravitreal bevacizumab (avastin) injection on retinal blood flow velocity in patients with choroidal neovascularization
-
This paper describes using an elegant technique early arterial and venous velocity changes after intravitreal bevacizumab
-
Barak A, Burgansky-Eliash Z, Barash H, et al. The effect of intravitreal bevacizumab (Avastin) injection on retinal blood flow velocity in patients with choroidal neovascularization. Eur J Ophthalmol 2012;22:423-30 This paper describes using an elegant technique early arterial and venous velocity changes after intravitreal bevacizumab.
-
(2012)
Eur J Ophthalmol
, vol.22
, pp. 423-30
-
-
Barak, A.1
Burgansky-Eliash, Z.2
Barash, H.3
-
39
-
-
84860839218
-
Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration
-
Hosseini H, Lotfi M, Esfahani MH, et al. Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration. Retina 2012;32:967-71
-
(2012)
Retina
, vol.32
, pp. 967-71
-
-
Hosseini, H.1
Lotfi, M.2
Esfahani, M.H.3
-
40
-
-
69049088006
-
The effect of intravitreal bevacizumab (avastin) administration on systemic hypertension
-
The findings of this study show that there is a risk of dysregulation of blood pressure levels or persistence of hypertension in hypertensive patients after intravitreal bevacizumab injections
-
Rasier R, Artunay O, Yuzbasioglu E, et al. The effect of intravitreal bevacizumab (avastin) administration on systemic hypertension. Eye (Lond) 2009;23:1714-18 The findings of this study show that there is a risk of dysregulation of blood pressure levels or persistence of hypertension in hypertensive patients after intravitreal bevacizumab injections
-
(2009)
Eye (Lond)
, vol.23
, pp. 1714-18
-
-
Rasier, R.1
Artunay, O.2
Yuzbasioglu, E.3
-
41
-
-
0024322659
-
Platelet ultrastructure and secretion in acute ischemic stroke
-
Joseph R, Riddle JM, Welch KM, et al. Platelet ultrastructure and secretion in acute ischemic stroke. Stroke 1989;20:1316-19 (Pubitemid 19254544)
-
(1989)
Stroke
, vol.20
, Issue.10
, pp. 1316-1319
-
-
Joseph, R.1
Riddle, J.M.2
Welch, K.M.A.3
D'Andrea, G.4
-
42
-
-
54249138238
-
Electron opaque structures in human platelets: Which are or are not dense bodies?
-
White JG. Electron opaque structures in human platelets: which are or are not dense bodies? Platelets 2008;19:455-66
-
(2008)
Platelets
, vol.19
, pp. 455-66
-
-
White, J.G.1
-
43
-
-
79959458021
-
Intravitreal anti-vegf therapy for neovascular age-related macular degeneration and the risk of stroke
-
Cleary CA, Sharaznayan D, Hickey-Dwyer M. Intravitreal anti-VEGF therapy for neovascular age-related macular degeneration and the risk of stroke. Ir Med J 2011;104:146-9
-
(2011)
Ir Med J
, vol.104
, pp. 146-9
-
-
Cleary, C.A.1
Sharaznayan, D.2
Hickey-Dwyer, M.3
-
44
-
-
84864569800
-
A safety review and meta-Analyses of bevacizumab and ranibizumab: Off-label versus goldstandard
-
Schmucker C, Ehlken C, Agostini HT, et al. A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: off-Label versus Goldstandard. PLoS ONE 2012;7:e42701
-
(2012)
PLoS ONE
, vol.7
-
-
Schmucker, C.1
Ehlken, C.2
Agostini, H.T.3
-
45
-
-
70349567396
-
Effect of intravitreal injection of high-dose bevacizumab in monkey eyes
-
Sakurai K, Akiyama H, Shimoda Y, et al. Effect of intravitreal injection of high-dose bevacizumab in monkey eyes. Invest Ophthalmol Vis Sci 2009;50:4905-16
-
(2009)
Invest Ophthalmol Vis Sci
, vol.50
, pp. 4905-16
-
-
Sakurai, K.1
Akiyama, H.2
Shimoda, Y.3
|